Ireland

Ireland

Hepatitis B

Download HBV data

Prevalence of chronic HBV (HBsAg+)

National
Download
Value (%) Year Type Source
0.1 (0.10 - 0.40) 2009 Survey/reported Talento AF, 2010
0.1 (0 - 0.40) 2003 Survey/reported Nardone A et al, 2009
0.04 (0.02 - 0.07) 2015 Modelled WHO
0.1 (0.10 - 0.10) 2016 Modelled Razavi-Shearer et al, 2018
0.03 (0.01 - 0.07) 2013 Modelled Schweitzer et al, 2015
0.62 (0.50 - 0.74) 2019 Modelled IHME, GBD 2019 (accessed 2020)
0.72 (0.58 - 0.84) 2018 Modelled IHME, GBD 2019 (accessed 2022)
0.73 (0.58 - 0.87) 2017 Modelled IHME, GBD 2019 (accessed 2022)
0.73 (0.59 - 0.86) 2016 Modelled IHME, GBD 2019 (accessed 2022)
0.73 (0.59 - 0.89) 2015 Modelled IHME, GBD 2019 (accessed 2022)
0.74 (0.60 - 0.89) 2014 Modelled IHME, GBD 2019 (accessed 2022)
0.75 (0.61 - 0.89) 2013 Modelled IHME, GBD 2019 (accessed 2022)
0.76 (0.63 - 0.90) 2012 Modelled IHME, GBD 2019 (accessed 2022)
0.77 (0.63 - 0.91) 2011 Modelled IHME, GBD 2019 (accessed 2022)
0.78 (0.64 - 0.92) 2010 Modelled IHME, GBD 2019 (accessed 2022)
0.79 (0.64 - 0.93) 2009 Modelled IHME, GBD 2019 (accessed 2022)
0.8 (0.65 - 0.94) 2008 Modelled IHME, GBD 2019 (accessed 2022)
0.81 (0.66 - 0.96) 2007 Modelled IHME, GBD 2019 (accessed 2022)
0.82 (0.67 - 0.97) 2006 Modelled IHME, GBD 2019 (accessed 2022)
0.83 (0.66 - 0.99) 2005 Modelled IHME, GBD 2019 (accessed 2022)
0.83 (0.67 - 0.99) 2004 Modelled IHME, GBD 2019 (accessed 2022)
0.83 (0.68 - 1) 2003 Modelled IHME, GBD 2019 (accessed 2022)
0.83 (0.68 - 1) 2002 Modelled IHME, GBD 2019 (accessed 2022)
0.83 (0.68 - 1.01) 2001 Modelled IHME, GBD 2019 (accessed 2022)
0.84 (0.69 - 1.02) 2000 Modelled IHME, GBD 2019 (accessed 2022)
0.84 (0.70 - 1.03) 1999 Modelled IHME, GBD 2019 (accessed 2022)
0.85 (0.70 - 1.03) 1998 Modelled IHME, GBD 2019 (accessed 2022)
0.86 (0.71 - 1.04) 1997 Modelled IHME, GBD 2019 (accessed 2022)
0.87 (0.71 - 1.04) 1996 Modelled IHME, GBD 2019 (accessed 2022)
0.87 (0.71 - 1.05) 1995 Modelled IHME, GBD 2019 (accessed 2022)
0.88 (0.72 - 1.05) 1994 Modelled IHME, GBD 2019 (accessed 2022)
0.88 (0.72 - 1.05) 1993 Modelled IHME, GBD 2019 (accessed 2022)
0.88 (0.73 - 1.05) 1992 Modelled IHME, GBD 2019 (accessed 2022)
0.88 (0.72 - 1.06) 1991 Modelled IHME, GBD 2019 (accessed 2022)
0.88 (0.70 - 1.07) 1990 Modelled IHME, GBD 2019 (accessed 2022)
0.69 (0.55 - 0.81) 2019 Modelled IHME, GBD 2019 (accessed 2022)
Showing out of
Show more
Children under-5 years
Download
Value (%) Year Type Source
0.01 (0 - 0.02) 2015 Modelled WHO
0.03 (0.02 - 0.04) 2019 Modelled IHME, GBD 2019 (accessed 2020)
0.05 (0.03 - 0.08) 2019 Modelled IHME, GBD 2019 (accessed 2022)
0.06 (0.04 - 0.09) 2018 Modelled IHME, GBD 2019 (accessed 2022)
0.06 (0.04 - 0.09) 2017 Modelled IHME, GBD 2019 (accessed 2022)
0.06 (0.04 - 0.09) 2016 Modelled IHME, GBD 2019 (accessed 2022)
0.06 (0.04 - 0.09) 2015 Modelled IHME, GBD 2019 (accessed 2022)
0.07 (0.05 - 0.10) 2014 Modelled IHME, GBD 2019 (accessed 2022)
0.1 (0.07 - 0.14) 2013 Modelled IHME, GBD 2019 (accessed 2022)
0.15 (0.10 - 0.20) 2012 Modelled IHME, GBD 2019 (accessed 2022)
0.2 (0.13 - 0.27) 2011 Modelled IHME, GBD 2019 (accessed 2022)
0.25 (0.15 - 0.33) 2010 Modelled IHME, GBD 2019 (accessed 2022)
0.31 (0.20 - 0.43) 2009 Modelled IHME, GBD 2019 (accessed 2022)
0.41 (0.26 - 0.55) 2008 Modelled IHME, GBD 2019 (accessed 2022)
0.5 (0.33 - 0.67) 2007 Modelled IHME, GBD 2019 (accessed 2022)
0.57 (0.38 - 0.79) 2006 Modelled IHME, GBD 2019 (accessed 2022)
0.6 (0.40 - 0.84) 2005 Modelled IHME, GBD 2019 (accessed 2022)
0.6 (0.40 - 0.82) 2004 Modelled IHME, GBD 2019 (accessed 2022)
0.6 (0.40 - 0.81) 2003 Modelled IHME, GBD 2019 (accessed 2022)
0.59 (0.40 - 0.81) 2002 Modelled IHME, GBD 2019 (accessed 2022)
0.59 (0.39 - 0.81) 2001 Modelled IHME, GBD 2019 (accessed 2022)
0.58 (0.39 - 0.80) 2000 Modelled IHME, GBD 2019 (accessed 2022)
0.59 (0.39 - 0.80) 1999 Modelled IHME, GBD 2019 (accessed 2022)
0.6 (0.41 - 0.81) 1998 Modelled IHME, GBD 2019 (accessed 2022)
0.61 (0.42 - 0.82) 1997 Modelled IHME, GBD 2019 (accessed 2022)
0.63 (0.43 - 0.84) 1996 Modelled IHME, GBD 2019 (accessed 2022)
0.64 (0.44 - 0.86) 1995 Modelled IHME, GBD 2019 (accessed 2022)
0.64 (0.44 - 0.86) 1994 Modelled IHME, GBD 2019 (accessed 2022)
0.64 (0.44 - 0.85) 1993 Modelled IHME, GBD 2019 (accessed 2022)
0.63 (0.43 - 0.86) 1992 Modelled IHME, GBD 2019 (accessed 2022)
0.63 (0.42 - 0.87) 1991 Modelled IHME, GBD 2019 (accessed 2022)
0.62 (0.40 - 0.88) 1990 Modelled IHME, GBD 2019 (accessed 2022)
0.04 (0.03 - 0.05) 2020 Modelled WHO
Showing out of
Show more
People who inject drugs (PWID)
Download
Value (%) Year Type Source
0.5 2010 Survey/reported ECDC
Prisoners
Download
Value (%) Year Type Source
0.3 (0 - 0.90) 2011 Survey/reported Drummond A et al, 2014.
0.3 2014 Survey/reported ECDC
Showing out of
Show more
Technical notes

Number of people living with chronic HBV

National
Download
Value Year Type Source
4,000 (4,000 - 5,000) 2016 Modelled Razavi-Shearer et al, 2018
30,495 (24,460 - 36,256) 2019 Modelled IHME, GBD 2019 (accessed 2020)
31,323 (25,172 - 37,055) 2019 Modelled IHME, GBD 2019 (accessed 2022)
32,570 (26,210 - 38,141) 2018 Modelled IHME, GBD 2019 (accessed 2022)
33,013 (26,472 - 39,124) 2017 Modelled IHME, GBD 2019 (accessed 2022)
32,851 (26,634 - 38,890) 2016 Modelled IHME, GBD 2019 (accessed 2022)
32,790 (26,481 - 39,607) 2015 Modelled IHME, GBD 2019 (accessed 2022)
32,881 (26,798 - 39,249) 2014 Modelled IHME, GBD 2019 (accessed 2022)
33,025 (26,905 - 39,099) 2013 Modelled IHME, GBD 2019 (accessed 2022)
33,161 (27,310 - 39,115) 2012 Modelled IHME, GBD 2019 (accessed 2022)
33,229 (27,190 - 39,303) 2011 Modelled IHME, GBD 2019 (accessed 2022)
33,163 (27,122 - 39,324) 2010 Modelled IHME, GBD 2019 (accessed 2022)
33,091 (26,952 - 39,104) 2009 Modelled IHME, GBD 2019 (accessed 2022)
33,095 (27,043 - 39,033) 2008 Modelled IHME, GBD 2019 (accessed 2022)
33,062 (26,828 - 39,052) 2007 Modelled IHME, GBD 2019 (accessed 2022)
32,890 (26,584 - 39,044) 2006 Modelled IHME, GBD 2019 (accessed 2022)
32,483 (26,126 - 38,815) 2005 Modelled IHME, GBD 2019 (accessed 2022)
31,929 (25,823 - 38,181) 2004 Modelled IHME, GBD 2019 (accessed 2022)
31,376 (25,574 - 37,647) 2003 Modelled IHME, GBD 2019 (accessed 2022)
30,855 (25,239 - 37,198) 2002 Modelled IHME, GBD 2019 (accessed 2022)
30,395 (24,868 - 36,932) 2001 Modelled IHME, GBD 2019 (accessed 2022)
30,004 (24,638 - 36,655) 2000 Modelled IHME, GBD 2019 (accessed 2022)
29,771 (24,591 - 36,304) 1999 Modelled IHME, GBD 2019 (accessed 2022)
29,714 (24,544 - 36,057) 1998 Modelled IHME, GBD 2019 (accessed 2022)
29,738 (24,529 - 35,884) 1997 Modelled IHME, GBD 2019 (accessed 2022)
29,757 (24,402 - 35,820) 1996 Modelled IHME, GBD 2019 (accessed 2022)
29,687 (24,138 - 35,687) 1995 Modelled IHME, GBD 2019 (accessed 2022)
29,563 (24,158 - 35,396) 1994 Modelled IHME, GBD 2019 (accessed 2022)
29,464 (24,194 - 35,188) 1993 Modelled IHME, GBD 2019 (accessed 2022)
29,382 (24,126 - 35,037) 1992 Modelled IHME, GBD 2019 (accessed 2022)
29,311 (23,758 - 35,427) 1991 Modelled IHME, GBD 2019 (accessed 2022)
29,255 (23,188 - 35,608) 1990 Modelled IHME, GBD 2019 (accessed 2022)
Showing out of
Show more

HBV-related death rate

National
Download
Value (per 100,000) Year Type Source
1.25 (0.95 - 1.62) 2019 Modelled IHME, GBD 2019 (accessed 2020)
0.8 (0.61 - 1.03) 1990 Modelled IHME, GBD 2019 (accessed 2022)
0.82 (0.63 - 1.05) 1991 Modelled IHME, GBD 2019 (accessed 2022)
0.84 (0.64 - 1.07) 1992 Modelled IHME, GBD 2019 (accessed 2022)
0.87 (0.67 - 1.12) 1993 Modelled IHME, GBD 2019 (accessed 2022)
0.89 (0.69 - 1.15) 1994 Modelled IHME, GBD 2019 (accessed 2022)
0.93 (0.72 - 1.19) 1995 Modelled IHME, GBD 2019 (accessed 2022)
1.02 (0.78 - 1.31) 1997 Modelled IHME, GBD 2019 (accessed 2022)
0.97 (0.75 - 1.24) 1996 Modelled IHME, GBD 2019 (accessed 2022)
1.07 (0.82 - 1.37) 1998 Modelled IHME, GBD 2019 (accessed 2022)
1.12 (0.87 - 1.44) 1999 Modelled IHME, GBD 2019 (accessed 2022)
1.18 (0.91 - 1.52) 2000 Modelled IHME, GBD 2019 (accessed 2022)
1.22 (0.94 - 1.57) 2001 Modelled IHME, GBD 2019 (accessed 2022)
1.24 (0.96 - 1.59) 2002 Modelled IHME, GBD 2019 (accessed 2022)
1.25 (0.97 - 1.60) 2003 Modelled IHME, GBD 2019 (accessed 2022)
1.33 (1.02 - 1.69) 2005 Modelled IHME, GBD 2019 (accessed 2022)
1.3 (1 - 1.66) 2004 Modelled IHME, GBD 2019 (accessed 2022)
1.38 (1.07 - 1.77) 2006 Modelled IHME, GBD 2019 (accessed 2022)
1.49 (1.15 - 1.88) 2008 Modelled IHME, GBD 2019 (accessed 2022)
1.44 (1.11 - 1.82) 2007 Modelled IHME, GBD 2019 (accessed 2022)
1.52 (1.19 - 1.93) 2010 Modelled IHME, GBD 2019 (accessed 2022)
1.55 (1.20 - 1.95) 2009 Modelled IHME, GBD 2019 (accessed 2022)
1.58 (1.23 - 2) 2011 Modelled IHME, GBD 2019 (accessed 2022)
1.6 (1.25 - 2.03) 2012 Modelled IHME, GBD 2019 (accessed 2022)
1.61 (1.25 - 2.05) 2013 Modelled IHME, GBD 2019 (accessed 2022)
1.59 (1.23 - 2.01) 2014 Modelled IHME, GBD 2019 (accessed 2022)
1.56 (1.20 - 2) 2017 Modelled IHME, GBD 2019 (accessed 2022)
1.59 (1.23 - 2.03) 2015 Modelled IHME, GBD 2019 (accessed 2022)
1.56 (1.20 - 1.99) 2016 Modelled IHME, GBD 2019 (accessed 2022)
1.46 (1.12 - 1.89) 2018 Modelled IHME, GBD 2019 (accessed 2022)
1.25 (0.95 - 1.62) 2019 Modelled IHME, GBD 2019 (accessed 2022)
Showing out of
Show more
Technical notes

HBV-related deaths

National
Download
Value Year Type Source
66 2016 Modelled WHO
29 (22 - 37) 1990 Modelled IHME, GBD 2019 (accessed 2022)
29 (23 - 38) 1991 Modelled IHME, GBD 2019 (accessed 2022)
30 (23 - 39) 1992 Modelled IHME, GBD 2019 (accessed 2022)
32 (24 - 41) 1993 Modelled IHME, GBD 2019 (accessed 2022)
33 (25 - 42) 1994 Modelled IHME, GBD 2019 (accessed 2022)
36 (28 - 46) 1996 Modelled IHME, GBD 2019 (accessed 2022)
34 (26 - 44) 1995 Modelled IHME, GBD 2019 (accessed 2022)
38 (29 - 49) 1997 Modelled IHME, GBD 2019 (accessed 2022)
40 (31 - 52) 1998 Modelled IHME, GBD 2019 (accessed 2022)
43 (33 - 55) 1999 Modelled IHME, GBD 2019 (accessed 2022)
46 (35 - 59) 2000 Modelled IHME, GBD 2019 (accessed 2022)
49 (38 - 64) 2002 Modelled IHME, GBD 2019 (accessed 2022)
48 (37 - 62) 2001 Modelled IHME, GBD 2019 (accessed 2022)
51 (40 - 65) 2003 Modelled IHME, GBD 2019 (accessed 2022)
54 (41 - 69) 2004 Modelled IHME, GBD 2019 (accessed 2022)
56 (43 - 72) 2005 Modelled IHME, GBD 2019 (accessed 2022)
60 (46 - 76) 2006 Modelled IHME, GBD 2019 (accessed 2022)
63 (49 - 80) 2007 Modelled IHME, GBD 2019 (accessed 2022)
66 (51 - 84) 2008 Modelled IHME, GBD 2019 (accessed 2022)
70 (55 - 89) 2009 Modelled IHME, GBD 2019 (accessed 2022)
74 (57 - 93) 2011 Modelled IHME, GBD 2019 (accessed 2022)
70 (55 - 89) 2010 Modelled IHME, GBD 2019 (accessed 2022)
75 (59 - 96) 2012 Modelled IHME, GBD 2019 (accessed 2022)
76 (59 - 97) 2013 Modelled IHME, GBD 2019 (accessed 2022)
77 (59 - 98) 2015 Modelled IHME, GBD 2019 (accessed 2022)
76 (59 - 96) 2014 Modelled IHME, GBD 2019 (accessed 2022)
76 (58 - 96) 2016 Modelled IHME, GBD 2019 (accessed 2022)
76 (58 - 97) 2017 Modelled IHME, GBD 2019 (accessed 2022)
71 (55 - 92) 2018 Modelled IHME, GBD 2019 (accessed 2022)
61 (47 - 80) 2019 Modelled IHME, GBD 2019 (accessed 2022)
61 (47 - 80) 2019 Modelled IHME, GBD 2019 (accessed 2020)
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HBV

National
Download
Value (%) Year Type Source
3 (2 - 4) 1990 Modelled IHME, GBD 2019 (accessed 2022)
3 (2 - 4) 1991 Modelled IHME, GBD 2019 (accessed 2022)
3 (2 - 4) 1992 Modelled IHME, GBD 2019 (accessed 2022)
3 (2 - 4) 1993 Modelled IHME, GBD 2019 (accessed 2022)
3 (2 - 4) 1994 Modelled IHME, GBD 2019 (accessed 2022)
3 (2 - 4) 1995 Modelled IHME, GBD 2019 (accessed 2022)
3 (2 - 5) 1996 Modelled IHME, GBD 2019 (accessed 2022)
4 (2 - 5) 1998 Modelled IHME, GBD 2019 (accessed 2022)
3 (2 - 5) 1997 Modelled IHME, GBD 2019 (accessed 2022)
4 (3 - 5) 1999 Modelled IHME, GBD 2019 (accessed 2022)
4 (3 - 6) 2000 Modelled IHME, GBD 2019 (accessed 2022)
4 (3 - 6) 2001 Modelled IHME, GBD 2019 (accessed 2022)
6 (4 - 8) 2004 Modelled IHME, GBD 2019 (accessed 2022)
5 (3 - 7) 2002 Modelled IHME, GBD 2019 (accessed 2022)
5 (4 - 7) 2003 Modelled IHME, GBD 2019 (accessed 2022)
6 (4 - 9) 2005 Modelled IHME, GBD 2019 (accessed 2022)
6 (4 - 9) 2006 Modelled IHME, GBD 2019 (accessed 2022)
7 (5 - 10) 2007 Modelled IHME, GBD 2019 (accessed 2022)
8 (5 - 11) 2008 Modelled IHME, GBD 2019 (accessed 2022)
8 (6 - 12) 2009 Modelled IHME, GBD 2019 (accessed 2022)
9 (6 - 13) 2010 Modelled IHME, GBD 2019 (accessed 2022)
10 (7 - 14) 2011 Modelled IHME, GBD 2019 (accessed 2022)
10 (7 - 14) 2012 Modelled IHME, GBD 2019 (accessed 2022)
10 (7 - 15) 2013 Modelled IHME, GBD 2019 (accessed 2022)
11 (7 - 15) 2015 Modelled IHME, GBD 2019 (accessed 2022)
11 (7 - 15) 2014 Modelled IHME, GBD 2019 (accessed 2022)
10 (7 - 15) 2017 Modelled IHME, GBD 2019 (accessed 2022)
10 (7 - 15) 2016 Modelled IHME, GBD 2019 (accessed 2022)
10 (7 - 14) 2018 Modelled IHME, GBD 2019 (accessed 2022)
9 (6 - 14) 2019 Modelled IHME, GBD 2019 (accessed 2022)
12 (8 - 17) 2019 Modelled IHME, GBD 2019 (accessed 2020)
Showing out of
Show more
Technical notes

Coverage of 3-dose hepatitis B vaccine

Infants
Download
Value (%) Year Type Source
93 2019 Survey/reported WHO/UNICEF
94 2020 Survey/reported WHO/UNICEF
93 2021 Survey/reported WHO/UNICEF
Showing out of
Show more
Technical notes

Number of needles/syringes per PWID per year

People who inject drugs (PWID)
Download
Value Year Type Source
46 (37 - 62) 2014 Survey/reported Health Research Board, 2014
Technical notes

Percent of PWID accessing OST

People who inject drugs (PWID)
Download
Value (%) Year Type Source
54 2017 Survey/reported EMCDDA, 2019
HBV National Action Plan
HBV elimination goal
HepB birth dose policy
No
Source: WHO
Eligible for HBV generic medicines
Source: WHO
HCV National Action Plan
Source:
HCV elimination goal
Source:
HCV testing policy
Risk-based
Source:
Eligible for HCV generic medicines
Source: MPP
At least one needle-syringe exchange program (NSP) operational
Yes
Source: Harm Reduction International
At least one opioid substitution therapy (OST) program operational
Yes
Source: Harm Reduction International
NSP in at least one prison
No
Source: Harm Reduction International
OST in at least one prison
Yes
Source: Harm Reduction International
% of substance use disorder facilities offering hepatitis testing
Most (61-100%)
Source: WHO
% of substance use disorder facilities offering hepatitis treatment
Some (11-30%)
Source: WHO

Hepatitis C

Download HCV data

Prevalence of chronic HCV (RNA+/cAg)

National
Download
Value (%) Year Type Source
0.6 (0.40 - 0.90) 2015 Modelled Blach et al, 2017
0.81 (0.66 - 0.99) 2019 Modelled IHME, GBD 2019 (accessed 2022)
0.8 (0.65 - 0.98) 2018 Modelled IHME, GBD 2019 (accessed 2022)
0.79 (0.64 - 0.98) 2017 Modelled IHME, GBD 2019 (accessed 2022)
0.78 (0.64 - 0.95) 2016 Modelled IHME, GBD 2019 (accessed 2022)
0.77 (0.63 - 0.95) 2015 Modelled IHME, GBD 2019 (accessed 2022)
0.76 (0.62 - 0.93) 2014 Modelled IHME, GBD 2019 (accessed 2022)
0.76 (0.62 - 0.93) 2013 Modelled IHME, GBD 2019 (accessed 2022)
0.76 (0.62 - 0.94) 2012 Modelled IHME, GBD 2019 (accessed 2022)
0.76 (0.62 - 0.94) 2011 Modelled IHME, GBD 2019 (accessed 2022)
0.76 (0.62 - 0.93) 2010 Modelled IHME, GBD 2019 (accessed 2022)
0.75 (0.62 - 0.92) 2009 Modelled IHME, GBD 2019 (accessed 2022)
0.75 (0.61 - 0.92) 2008 Modelled IHME, GBD 2019 (accessed 2022)
0.75 (0.61 - 0.91) 2007 Modelled IHME, GBD 2019 (accessed 2022)
0.74 (0.60 - 0.90) 2006 Modelled IHME, GBD 2019 (accessed 2022)
0.74 (0.60 - 0.90) 2005 Modelled IHME, GBD 2019 (accessed 2022)
0.73 (0.60 - 0.90) 2004 Modelled IHME, GBD 2019 (accessed 2022)
0.73 (0.59 - 0.89) 2003 Modelled IHME, GBD 2019 (accessed 2022)
0.72 (0.59 - 0.88) 2002 Modelled IHME, GBD 2019 (accessed 2022)
0.71 (0.58 - 0.88) 2001 Modelled IHME, GBD 2019 (accessed 2022)
0.71 (0.58 - 0.88) 2000 Modelled IHME, GBD 2019 (accessed 2022)
0.7 (0.57 - 0.87) 1999 Modelled IHME, GBD 2019 (accessed 2022)
0.69 (0.56 - 0.85) 1998 Modelled IHME, GBD 2019 (accessed 2022)
0.69 (0.56 - 0.84) 1997 Modelled IHME, GBD 2019 (accessed 2022)
0.68 (0.55 - 0.83) 1996 Modelled IHME, GBD 2019 (accessed 2022)
0.67 (0.54 - 0.82) 1995 Modelled IHME, GBD 2019 (accessed 2022)
0.67 (0.54 - 0.81) 1994 Modelled IHME, GBD 2019 (accessed 2022)
0.66 (0.54 - 0.81) 1993 Modelled IHME, GBD 2019 (accessed 2022)
0.66 (0.54 - 0.81) 1992 Modelled IHME, GBD 2019 (accessed 2022)
0.66 (0.53 - 0.81) 1991 Modelled IHME, GBD 2019 (accessed 2022)
0.65 (0.53 - 0.81) 1990 Modelled IHME, GBD 2019 (accessed 2022)
0.74 (0.61 - 0.91) 2019 Modelled IHME, GBD 2019 (accessed 2020)
Showing out of
Show more
Women of childbearing age (15–49 years)
Download
Value (%) Year Type Source
0.37 (0.25 - 0.54) 2019 Modelled Dugan et al., 2021
Technical notes

Prevalence of anti-HCV

National
Download
Value (%) Year Type Source
0.1 (0 - 0.40) 2009 Survey/reported Talento AF, 2010
1.1 (0.70 - 1.60) 2014 Modelled Gower et al, 2014
Showing out of
Show more
People who inject drugs (PWID)
Download
Value (%) Year Type Source
74.6 (72.30 - 76.90) 2003 Modelled Nelson P et al, 2011
41.5 2010 Survey/reported ECDC
Showing out of
Show more
Prisoners
Download
Value (%) Year Type Source
12.9 (10.60 - 15.40) 2014 Survey/reported Drummond A et al, 2014.
12.9 2014 Survey/reported ECDC
Showing out of
Show more
Technical notes

Number of people living with chronic HCV (RNA+/cAg)

National
Download
Value Year Type Source
30,000 (20,000 - 42,000) 2015 Modelled Blach et al, 2017
21,653 (17,534 - 26,887) 1990 Modelled IHME, GBD 2019 (accessed 2022)
21,803 (17,737 - 26,948) 1991 Modelled IHME, GBD 2019 (accessed 2022)
21,999 (17,880 - 26,949) 1992 Modelled IHME, GBD 2019 (accessed 2022)
22,235 (18,056 - 27,153) 1993 Modelled IHME, GBD 2019 (accessed 2022)
22,512 (18,272 - 27,409) 1994 Modelled IHME, GBD 2019 (accessed 2022)
22,836 (18,419 - 27,793) 1995 Modelled IHME, GBD 2019 (accessed 2022)
23,227 (18,808 - 28,301) 1996 Modelled IHME, GBD 2019 (accessed 2022)
23,698 (19,272 - 29,035) 1997 Modelled IHME, GBD 2019 (accessed 2022)
24,229 (19,747 - 29,901) 1998 Modelled IHME, GBD 2019 (accessed 2022)
24,788 (20,160 - 30,627) 1999 Modelled IHME, GBD 2019 (accessed 2022)
25,365 (20,650 - 31,536) 2000 Modelled IHME, GBD 2019 (accessed 2022)
25,980 (21,191 - 32,194) 2001 Modelled IHME, GBD 2019 (accessed 2022)
26,659 (21,824 - 32,819) 2002 Modelled IHME, GBD 2019 (accessed 2022)
27,390 (22,378 - 33,446) 2003 Modelled IHME, GBD 2019 (accessed 2022)
28,137 (22,924 - 34,322) 2004 Modelled IHME, GBD 2019 (accessed 2022)
28,882 (23,440 - 35,329) 2005 Modelled IHME, GBD 2019 (accessed 2022)
29,616 (24,119 - 36,039) 2006 Modelled IHME, GBD 2019 (accessed 2022)
30,341 (24,814 - 36,899) 2007 Modelled IHME, GBD 2019 (accessed 2022)
31,050 (25,432 - 37,918) 2008 Modelled IHME, GBD 2019 (accessed 2022)
31,717 (25,984 - 38,816) 2009 Modelled IHME, GBD 2019 (accessed 2022)
32,335 (26,360 - 39,697) 2010 Modelled IHME, GBD 2019 (accessed 2022)
32,834 (26,841 - 40,166) 2011 Modelled IHME, GBD 2019 (accessed 2022)
33,197 (27,182 - 40,579) 2012 Modelled IHME, GBD 2019 (accessed 2022)
33,509 (27,430 - 40,919) 2013 Modelled IHME, GBD 2019 (accessed 2022)
33,836 (27,760 - 41,315) 2014 Modelled IHME, GBD 2019 (accessed 2022)
34,260 (27,984 - 42,207) 2015 Modelled IHME, GBD 2019 (accessed 2022)
34,944 (28,726 - 42,625) 2016 Modelled IHME, GBD 2019 (accessed 2022)
35,655 (29,005 - 44,114) 2017 Modelled IHME, GBD 2019 (accessed 2022)
36,247 (29,660 - 44,348) 2018 Modelled IHME, GBD 2019 (accessed 2022)
36,453 (29,830 - 44,742) 2019 Modelled IHME, GBD 2019 (accessed 2020)
36,831 (30,198 - 45,126) 2019 Modelled IHME, GBD 2019 (accessed 2022)
Showing out of
Show more
Women of childbearing age (15–49 years)
Download
Value Year Type Source
4,400 (3,000 - 6,300) 2019 Modelled Dugan et al., 2021

HCV-related death rate

National
Download
Value (Deaths per 100,000) Year Type Source
3.41 (2.71 - 4.15) 2019 Modelled IHME, GBD 2019 (accessed 2020)
1.58 (1.27 - 1.96) 1990 Modelled IHME, GBD 2019 (accessed 2022)
1.63 (1.31 - 2.02) 1991 Modelled IHME, GBD 2019 (accessed 2022)
1.66 (1.33 - 2.05) 1992 Modelled IHME, GBD 2019 (accessed 2022)
1.72 (1.39 - 2.12) 1993 Modelled IHME, GBD 2019 (accessed 2022)
1.76 (1.42 - 2.17) 1994 Modelled IHME, GBD 2019 (accessed 2022)
1.89 (1.53 - 2.33) 1996 Modelled IHME, GBD 2019 (accessed 2022)
1.83 (1.46 - 2.24) 1995 Modelled IHME, GBD 2019 (accessed 2022)
2.08 (1.67 - 2.54) 1998 Modelled IHME, GBD 2019 (accessed 2022)
1.99 (1.60 - 2.45) 1997 Modelled IHME, GBD 2019 (accessed 2022)
2.18 (1.76 - 2.68) 1999 Modelled IHME, GBD 2019 (accessed 2022)
2.29 (1.85 - 2.80) 2000 Modelled IHME, GBD 2019 (accessed 2022)
2.37 (1.91 - 2.89) 2001 Modelled IHME, GBD 2019 (accessed 2022)
2.42 (1.95 - 2.96) 2002 Modelled IHME, GBD 2019 (accessed 2022)
2.46 (1.98 - 3) 2003 Modelled IHME, GBD 2019 (accessed 2022)
2.54 (2.06 - 3.10) 2004 Modelled IHME, GBD 2019 (accessed 2022)
2.62 (2.12 - 3.20) 2005 Modelled IHME, GBD 2019 (accessed 2022)
2.7 (2.20 - 3.30) 2006 Modelled IHME, GBD 2019 (accessed 2022)
2.83 (2.31 - 3.45) 2007 Modelled IHME, GBD 2019 (accessed 2022)
2.93 (2.40 - 3.56) 2008 Modelled IHME, GBD 2019 (accessed 2022)
3.08 (2.50 - 3.72) 2010 Modelled IHME, GBD 2019 (accessed 2022)
3.06 (2.51 - 3.72) 2009 Modelled IHME, GBD 2019 (accessed 2022)
3.25 (2.65 - 3.93) 2011 Modelled IHME, GBD 2019 (accessed 2022)
3.33 (2.74 - 4.02) 2012 Modelled IHME, GBD 2019 (accessed 2022)
3.43 (2.81 - 4.12) 2013 Modelled IHME, GBD 2019 (accessed 2022)
3.44 (2.80 - 4.18) 2014 Modelled IHME, GBD 2019 (accessed 2022)
3.46 (2.79 - 4.18) 2015 Modelled IHME, GBD 2019 (accessed 2022)
3.36 (2.69 - 4.06) 2017 Modelled IHME, GBD 2019 (accessed 2022)
3.38 (2.71 - 4.07) 2016 Modelled IHME, GBD 2019 (accessed 2022)
3.38 (2.70 - 4.07) 2018 Modelled IHME, GBD 2019 (accessed 2022)
3.41 (2.71 - 4.15) 2019 Modelled IHME, GBD 2019 (accessed 2022)
Showing out of
Show more
Technical notes

HCV-related deaths

National
Download
Value Year Type Source
245 2016 Modelled WHO
168 (133 - 204) 2019 Modelled IHME, GBD 2019 (accessed 2022)
168 (133 - 204) 2019 Modelled IHME, GBD 2019 (accessed 2020)
165 (132 - 199) 2018 Modelled IHME, GBD 2019 (accessed 2022)
164 (131 - 198) 2017 Modelled IHME, GBD 2019 (accessed 2022)
163 (131 - 197) 2016 Modelled IHME, GBD 2019 (accessed 2022)
166 (134 - 201) 2015 Modelled IHME, GBD 2019 (accessed 2022)
165 (134 - 200) 2014 Modelled IHME, GBD 2019 (accessed 2022)
163 (133 - 196) 2013 Modelled IHME, GBD 2019 (accessed 2022)
157 (129 - 189) 2012 Modelled IHME, GBD 2019 (accessed 2022)
151 (124 - 183) 2011 Modelled IHME, GBD 2019 (accessed 2022)
141 (115 - 171) 2010 Modelled IHME, GBD 2019 (accessed 2022)
139 (114 - 169) 2009 Modelled IHME, GBD 2019 (accessed 2022)
131 (107 - 159) 2008 Modelled IHME, GBD 2019 (accessed 2022)
124 (101 - 151) 2007 Modelled IHME, GBD 2019 (accessed 2022)
116 (95 - 142) 2006 Modelled IHME, GBD 2019 (accessed 2022)
111 (90 - 135) 2005 Modelled IHME, GBD 2019 (accessed 2022)
105 (85 - 129) 2004 Modelled IHME, GBD 2019 (accessed 2022)
100 (81 - 122) 2003 Modelled IHME, GBD 2019 (accessed 2022)
97 (78 - 118) 2002 Modelled IHME, GBD 2019 (accessed 2022)
93 (75 - 114) 2001 Modelled IHME, GBD 2019 (accessed 2022)
88 (72 - 108) 2000 Modelled IHME, GBD 2019 (accessed 2022)
83 (67 - 102) 1999 Modelled IHME, GBD 2019 (accessed 2022)
78 (63 - 96) 1998 Modelled IHME, GBD 2019 (accessed 2022)
74 (60 - 91) 1997 Modelled IHME, GBD 2019 (accessed 2022)
70 (56 - 86) 1996 Modelled IHME, GBD 2019 (accessed 2022)
67 (54 - 82) 1995 Modelled IHME, GBD 2019 (accessed 2022)
64 (52 - 79) 1994 Modelled IHME, GBD 2019 (accessed 2022)
62 (50 - 77) 1993 Modelled IHME, GBD 2019 (accessed 2022)
60 (48 - 74) 1992 Modelled IHME, GBD 2019 (accessed 2022)
59 (47 - 73) 1991 Modelled IHME, GBD 2019 (accessed 2022)
57 (46 - 71) 1990 Modelled IHME, GBD 2019 (accessed 2022)
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HCV

National
Download
Value (%) Year Type Source
8 (6 - 10) 1990 Modelled IHME, GBD 2019 (accessed 2022)
8 (6 - 10) 1991 Modelled IHME, GBD 2019 (accessed 2022)
8 (6 - 11) 1992 Modelled IHME, GBD 2019 (accessed 2022)
9 (7 - 11) 1993 Modelled IHME, GBD 2019 (accessed 2022)
9 (7 - 12) 1994 Modelled IHME, GBD 2019 (accessed 2022)
10 (7 - 12) 1996 Modelled IHME, GBD 2019 (accessed 2022)
9 (7 - 12) 1995 Modelled IHME, GBD 2019 (accessed 2022)
10 (8 - 13) 1997 Modelled IHME, GBD 2019 (accessed 2022)
11 (8 - 14) 1998 Modelled IHME, GBD 2019 (accessed 2022)
12 (9 - 15) 1999 Modelled IHME, GBD 2019 (accessed 2022)
13 (9 - 16) 2000 Modelled IHME, GBD 2019 (accessed 2022)
14 (10 - 17) 2001 Modelled IHME, GBD 2019 (accessed 2022)
16 (12 - 20) 2003 Modelled IHME, GBD 2019 (accessed 2022)
18 (13 - 22) 2004 Modelled IHME, GBD 2019 (accessed 2022)
15 (11 - 19) 2002 Modelled IHME, GBD 2019 (accessed 2022)
19 (14 - 24) 2005 Modelled IHME, GBD 2019 (accessed 2022)
20 (15 - 25) 2006 Modelled IHME, GBD 2019 (accessed 2022)
22 (17 - 27) 2007 Modelled IHME, GBD 2019 (accessed 2022)
23 (18 - 29) 2008 Modelled IHME, GBD 2019 (accessed 2022)
28 (21 - 35) 2010 Modelled IHME, GBD 2019 (accessed 2022)
25 (19 - 32) 2009 Modelled IHME, GBD 2019 (accessed 2022)
31 (24 - 39) 2012 Modelled IHME, GBD 2019 (accessed 2022)
30 (23 - 37) 2011 Modelled IHME, GBD 2019 (accessed 2022)
33 (25 - 42) 2013 Modelled IHME, GBD 2019 (accessed 2022)
34 (26 - 43) 2014 Modelled IHME, GBD 2019 (accessed 2022)
34 (26 - 43) 2015 Modelled IHME, GBD 2019 (accessed 2022)
33 (24 - 42) 2017 Modelled IHME, GBD 2019 (accessed 2022)
33 (25 - 42) 2016 Modelled IHME, GBD 2019 (accessed 2022)
32 (24 - 41) 2018 Modelled IHME, GBD 2019 (accessed 2022)
31 (23 - 40) 2019 Modelled IHME, GBD 2019 (accessed 2022)
39 (29 - 49) 2019 Modelled IHME, GBD 2019 (accessed 2020)
Showing out of
Show more
Technical notes

Number of persons treated for HCV

National
Download
Value Year Type Source
911 2017 Survey/reported ECDC, 2019
911 2017 Survey/reported The European Centre for Disease Prevention and Control, 2019
Showing out of
Show more
Technical notes

Number of needles/syringes per PWID per year

People who inject drugs (PWID)
Download
Value Year Type Source
46 (37 - 62) 2014 Survey/reported Health Research Board, 2014
Technical notes

Percent of PWID accessing OST

People who inject drugs (PWID)
Download
Value (%) Year Type Source
54 2017 Survey/reported EMCDDA, 2019
HBV National Action Plan
HBV elimination goal
HepB birth dose policy
No
Source: WHO
Eligible for HBV generic medicines
Source: WHO
HCV National Action Plan
Source:
HCV elimination goal
Source:
HCV testing policy
Risk-based
Source:
Eligible for HCV generic medicines
Source: MPP
At least one needle-syringe exchange program (NSP) operational
Yes
Source: Harm Reduction International
At least one opioid substitution therapy (OST) program operational
Yes
Source: Harm Reduction International
NSP in at least one prison
No
Source: Harm Reduction International
OST in at least one prison
Yes
Source: Harm Reduction International
% of substance use disorder facilities offering hepatitis testing
Most (61-100%)
Source: WHO
% of substance use disorder facilities offering hepatitis treatment
Some (11-30%)
Source: WHO

Overview

HBV elimination goal
HCV elimination goal

Prevalence (national)

Modelled

HBV (HBsAg+)
0.69 (%)
2019
(0.55 - 0.81(%))
IHME, GBD 2019 (accessed 2022)
HCV (RNA/cAg+)
0.74 (%)
2019
(0.61 - 0.91(%))
IHME, GBD 2019 (accessed 2020)

Survey/surveillance

HBV (HBsAg+)
0.1 (%)
2009
(0.1 - 0.4(%))
Talento AF, 2010
HCV (anti-HCV)
0.1 (%)
2009
(0 - 0.4(%))
Talento AF, 2010

Hepatitis related deaths (national)

Modelled

HBV
61
2019
(47 - 80)
IHME, GBD 2019 (accessed 2022)

Survey/surveillance

No data available
HBV chart

Modelled

HCV
168
2019
(133 - 204)
IHME, GBD 2019 (accessed 2022)

Survey/surveillance

No data available
HCV chart

Prevalence < 5

HBV
0.04 (%)
2020, latest modelled
(0.03 - 0.05(%))
WHO

Prevalence PWID

HCV
41.50 (%)
2010, survey/surveillance
ECDC

Birth dose vaccination coverage (national)

Survey/surveillance

No data available

No. of syringes/PWID/year

Survey/surveillance

HCV
46
2014
(37 - 62)
Health Research Board, 2014
Eligible for HBV generic medicines
Eligible for HCV generic medicines

Latest news

View all

News

Resources

Programs